Fluocinolone Acetonide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00591 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 50 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hypertrophic lichen planus | KG + DL |
| 2 | lichen planus pigmentosus | KG + DL |
| 3 | annular atrophic lichen planus | KG + DL |
| 4 | lichen planus pemphigoides | KG + DL |
| 5 | acrodermatitis chronica atrophicans | KG + DL |
| 6 | acne keloid | KG + DL |
| 7 | neonatal dermatomyositis | KG + DL |
| 8 | alopecia universalis onychodystrophy vitiligo | KG + DL |
| 9 | alopecia areata | KG + DL |
| 10 | alopecia mucinosa | KG + DL |
| 11 | telogen effluvium | KG + DL |
| 12 | secondary interstitial lung disease specific to childhood associated with a connective tissue disease | KG + DL |
| 13 | hydroa vacciniforme, familial | KG + DL |
| 14 | amyopathic dermatomyositis | KG + DL |
| 15 | Quinquaud’s folliculitis decalvans | KG + DL |
| 16 | vulvar inverted follicular keratosis | KG + DL |
| 17 | hereditary hypotrichosis with recurrent skin vesicles | KG + DL |
| 18 | alopecia antibody deficiency | KG + DL |
| 19 | alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome | KG + DL |
| 20 | 2-hydroxyethyl methacrylate sensitization | KG + DL |
| 21 | lichen planus, familial | KG + DL |
| 22 | primary cutaneous B-cell lymphoma | KG + DL |
| 23 | atrichia with papular lesions | KG + DL |
| 24 | psoriasis | KG + DL |
| 25 | parapsoriasis | KG + DL |
| 26 | pityriasis lichenoides | KG + DL |
| 27 | polyp of vocal cord | KG + DL |
| 28 | acute generalized exanthematous pustulosis | KG + DL |
| 29 | polyp of middle ear | KG + DL |
| 30 | autoimmune bullous skin disease | KG + DL |
| 31 | lipodermatosclerosis | KG + DL |
| 32 | acanthosis nigricans (disease) | KG + DL |
| 33 | acute lichenoid pityriasis | KG + DL |
| 34 | uterine polyp | KG + DL |
| 35 | epulis | KG + DL |
| 36 | polyp of frontal sinus | KG + DL |
| 37 | cutaneous vasculitis | KG + DL |
| 38 | fibroepithelial polyp | KG + DL |
| 39 | polyp of ureter | KG + DL |
| 40 | polyp of external auditory canal | KG + DL |
| 41 | pityriasis rosea | KG + DL |
| 42 | neoplastic polyp | KG + DL |
| 43 | vitiligo | KG + DL |
| 44 | polyp of vulva | KG + DL |
| 45 | intertrigo | KG + DL |
| 46 | neurotic excoriation | KG + DL |
| 47 | granulomatous dermatitis | KG + DL |
| 48 | spongiotic dermatitis | KG + DL |
| 49 | persistent polyclonal B-cell lymphocytosis | KG + DL |
| 50 | lichen sclerosus et atrophicus | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.